By far the most common cancer in women is breast cancer. Men can also be affected by breast cancer – about one percent of cases.
Incidence rates for breast cancer show that approximately one in eight women will develop it during their lifetime. Around 30 percent of those diagnosed with breast cancer were under 55 years old when they were diagnosed.
Our breast cancer enzyme slows the spread and growth of cancer cells in the body. To evade the body's natural immune defenses, cancer cells use various strategies. To migrate undetected to other parts of the body, they camouflage themselves with a coating of a substance produced by the body itself. However, the breast cancer enzyme can recognize these cells and destroy them, effectively preventing metastases.
Cancer cells can also produce structures that are classified as harmful by the immune system and destroyed. This allows living cancer cells to remain undetected and proliferate freely. This deception is also undermined by the cancer enzyme, which can cleave these camouflaged structures.